Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 1294 entries
View as:

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT00877526 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01697631 Org: User:
Start: 07/22/02 End: 04/24/03 Due: 04/24/04

Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01230021 Org: User:
Start: 11/30/10 End: 01/31/12 Due: 01/31/13

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Phase: N/A Priority: Normal
NCT ID: NCT03449342 Org: User:
Start: 03/01/18 End: 04/22/19 Due: 04/22/20

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Phase: N/A Priority: Normal
NCT ID: NCT03430154 Org: User:
Start: 12/01/17 End: 04/29/18 Due: 04/29/19

Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities

Phase: N/A Priority: Normal
NCT ID: NCT04584892 Org: User:
Start: 04/12/21 End: 03/27/23 Due: 03/27/24

Observational Study on Levemir® in Obese Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00849342 Org: User:
Start: 12/31/08 End: 01/31/13 Due: 01/31/14

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04916470 Org: User:
Start: 06/15/21 End: 10/11/23 Due: 10/11/24

Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01865331 Org: User:
Start: 12/31/06 End: 03/31/07 Due: 03/31/08

A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT02911948 Org: User:
Start: 09/21/16 End: 11/22/17 Due: 11/22/18

A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01059812 Org: User:
Start: 02/01/10 End: 12/23/10 Due: 12/23/11

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04537637 Org: User:
Start: 08/28/20 End: 05/08/23 Due: 05/08/24

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02305381 Org: User:
Start: 12/01/14 End: 11/21/15 Due: 11/21/16

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01489644 Org: User:
Start: 06/30/06 End: 07/31/06 Due: 07/31/07

Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00411892 Org: User:
Start: 11/29/06 End: 03/18/08 Due: 03/18/09

Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00822185 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03799198 Org: User:
Start: 01/07/19 End: 05/22/20 Due: 05/22/21

A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)

Phase: N/A Priority: Normal
NCT ID: NCT05646706 Org: User:
Start: 01/04/23 End: 11/26/24 Due: 11/26/25

Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02249910 Org: User:
Start: 09/18/14 End: 03/06/15 Due: 03/06/16

Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

Phase: N/A Priority: Normal
NCT ID: NCT01536626 Org: User:
Start: 06/09/06 End: 04/10/07 Due: 04/10/08

China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)

Phase: N/A Priority: Normal
NCT ID: NCT05221580 Org: User:
Start: 03/18/22 End: 03/31/23 Due: 03/31/24

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00671008 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00761540 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01223911 Org: User:
Start: 01/31/11 End: 02/28/13 Due: 02/28/14

A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02964104 Org: User:
Start: 11/15/16 End: 12/12/17 Due: 12/12/18